Atlas Trials

Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder

Clinical trial NCT07253207 · COMPLETED

Trial details

NCT number
NCT07253207
Sponsor
Zhejiang Huahai Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder (MDD)
Start date
2024-10-17
Primary completion
2025-06-13
Enrollment
392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.